2019
DOI: 10.1002/med.21630
|View full text |Cite
|
Sign up to set email alerts
|

Back Cover Image, Volume 39, Issue 5

Abstract: Description of the back cover image: The cover image is based on the Review Article Rhodiola species: A comprehensive review of traditional use, phytochemistry, pharmacology, toxicity, and clinical study by Hongxun Tao et al., https://doi.org/10.1002/med.21564. Cover image © Hongxun Tao, Xu Wu, Shengpeng Wang, Prof. Yitao Wang.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…1−3 The genus Rhodiola is native to the Arctic regions of Europe, Asia, and North America and comprises over 200 species. 1,3,4 Phytochemical studies report R. rosea to be rich in cinnamyl alcohol glycosides, salidroside and its aglycone, monoterpenoid glycosides, benzyl alcohol glycosides, cyanogenic glycosides, and flavonoids. While cinnamyl alcohol glycosides and salidroside have been comprehensively investigated and are considered the bioactive constituents, some investigations suggest that geraniol-type monoterpenoids might play a critical role in the treatment of specific conditions, such as in depression and senile dementia.…”
mentioning
confidence: 99%
“…1−3 The genus Rhodiola is native to the Arctic regions of Europe, Asia, and North America and comprises over 200 species. 1,3,4 Phytochemical studies report R. rosea to be rich in cinnamyl alcohol glycosides, salidroside and its aglycone, monoterpenoid glycosides, benzyl alcohol glycosides, cyanogenic glycosides, and flavonoids. While cinnamyl alcohol glycosides and salidroside have been comprehensively investigated and are considered the bioactive constituents, some investigations suggest that geraniol-type monoterpenoids might play a critical role in the treatment of specific conditions, such as in depression and senile dementia.…”
mentioning
confidence: 99%